EGFR-Phosphorylated Platelet Isoform of Phosphofructokinase 1 Promotes PI3K Activation

Jong Ho Lee, Rui Liu, Jing Li, Yugang Wang, Lin Tan, Xin Jian Li, Xu Qian, Chuanbao Zhang, Yan Xia, Daqian Xu, Wei Guo, Zhiyong Ding, Linyong Du, Yanhua Zheng, Qianming Chen, Philip L. Lorenzi, Gordon Mills, Tao Jiang, Zhimin Lu

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

EGFR activates phosphatidylinositide 3-kinase (PI3K), but the mechanism underlying this activation is not completely understood. We demonstrated here that EGFR activation resulted in lysine acetyltransferase 5 (KAT5)-mediated K395 acetylation of the platelet isoform of phosphofructokinase 1 (PFKP) and subsequent translocation of PFKP to the plasma membrane, where the PFKP was phosphorylated at Y64 by EGFR. Phosphorylated PFKP binds to the N-terminal SH2 domain of p85α, which is distinct from binding of Gab1 to the C-terminal SH2 domain of p85α, and recruited p85α to the plasma membrane resulting in PI3K activation. PI3K-dependent AKT activation results in enhanced phosphofructokinase 2 (PFK2) phosphorylation and production of fructose-2,6-bisphosphate, which in turn promotes PFK1 activation. PFKP Y64 phosphorylation–enhanced PI3K/AKT-dependent PFK1 activation and GLUT1 expression promoted the Warburg effect, tumor cell proliferation, and brain tumorigenesis. These findings underscore the instrumental role of PFKP in PI3K activation and enhanced glycolysis through PI3K/AKT-dependent positive-feedback regulation. Lee et al. demonstrate that KAT5-mediated PFKP acetylation and subsequent EGFR-phosphorylated PFKP bind to the N-terminal SH2 domain of p85α to activate PI3K, leading to enhanced AKT-dependent PFK2 activation, F-2,6-BP-production-dependent PFK1 activation, and GLUT1 expression. Non-metabolic function of PFKP promotes the Warburg effect through PI3K/AKT-dependent positive-feedback regulation.

Original languageEnglish (US)
Pages (from-to)197-210.e7
JournalMolecular Cell
Volume70
Issue number2
DOIs
StatePublished - Apr 19 2018
Externally publishedYes

Fingerprint

Phosphofructokinase-1
Protein Isoforms
Phosphotransferases
Blood Platelets
src Homology Domains
Phosphofructokinase-2
Acetylation
Cell Membrane
Glycolysis
Carcinogenesis
Phosphorylation
Cell Proliferation

Keywords

  • EGFR
  • PFKP
  • phosphorylation
  • PI3K
  • the Warburg effect

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

Lee, J. H., Liu, R., Li, J., Wang, Y., Tan, L., Li, X. J., ... Lu, Z. (2018). EGFR-Phosphorylated Platelet Isoform of Phosphofructokinase 1 Promotes PI3K Activation. Molecular Cell, 70(2), 197-210.e7. https://doi.org/10.1016/j.molcel.2018.03.018

EGFR-Phosphorylated Platelet Isoform of Phosphofructokinase 1 Promotes PI3K Activation. / Lee, Jong Ho; Liu, Rui; Li, Jing; Wang, Yugang; Tan, Lin; Li, Xin Jian; Qian, Xu; Zhang, Chuanbao; Xia, Yan; Xu, Daqian; Guo, Wei; Ding, Zhiyong; Du, Linyong; Zheng, Yanhua; Chen, Qianming; Lorenzi, Philip L.; Mills, Gordon; Jiang, Tao; Lu, Zhimin.

In: Molecular Cell, Vol. 70, No. 2, 19.04.2018, p. 197-210.e7.

Research output: Contribution to journalArticle

Lee, JH, Liu, R, Li, J, Wang, Y, Tan, L, Li, XJ, Qian, X, Zhang, C, Xia, Y, Xu, D, Guo, W, Ding, Z, Du, L, Zheng, Y, Chen, Q, Lorenzi, PL, Mills, G, Jiang, T & Lu, Z 2018, 'EGFR-Phosphorylated Platelet Isoform of Phosphofructokinase 1 Promotes PI3K Activation', Molecular Cell, vol. 70, no. 2, pp. 197-210.e7. https://doi.org/10.1016/j.molcel.2018.03.018
Lee, Jong Ho ; Liu, Rui ; Li, Jing ; Wang, Yugang ; Tan, Lin ; Li, Xin Jian ; Qian, Xu ; Zhang, Chuanbao ; Xia, Yan ; Xu, Daqian ; Guo, Wei ; Ding, Zhiyong ; Du, Linyong ; Zheng, Yanhua ; Chen, Qianming ; Lorenzi, Philip L. ; Mills, Gordon ; Jiang, Tao ; Lu, Zhimin. / EGFR-Phosphorylated Platelet Isoform of Phosphofructokinase 1 Promotes PI3K Activation. In: Molecular Cell. 2018 ; Vol. 70, No. 2. pp. 197-210.e7.
@article{9f3a1ecd19b34f79822903c89075d4c2,
title = "EGFR-Phosphorylated Platelet Isoform of Phosphofructokinase 1 Promotes PI3K Activation",
abstract = "EGFR activates phosphatidylinositide 3-kinase (PI3K), but the mechanism underlying this activation is not completely understood. We demonstrated here that EGFR activation resulted in lysine acetyltransferase 5 (KAT5)-mediated K395 acetylation of the platelet isoform of phosphofructokinase 1 (PFKP) and subsequent translocation of PFKP to the plasma membrane, where the PFKP was phosphorylated at Y64 by EGFR. Phosphorylated PFKP binds to the N-terminal SH2 domain of p85α, which is distinct from binding of Gab1 to the C-terminal SH2 domain of p85α, and recruited p85α to the plasma membrane resulting in PI3K activation. PI3K-dependent AKT activation results in enhanced phosphofructokinase 2 (PFK2) phosphorylation and production of fructose-2,6-bisphosphate, which in turn promotes PFK1 activation. PFKP Y64 phosphorylation–enhanced PI3K/AKT-dependent PFK1 activation and GLUT1 expression promoted the Warburg effect, tumor cell proliferation, and brain tumorigenesis. These findings underscore the instrumental role of PFKP in PI3K activation and enhanced glycolysis through PI3K/AKT-dependent positive-feedback regulation. Lee et al. demonstrate that KAT5-mediated PFKP acetylation and subsequent EGFR-phosphorylated PFKP bind to the N-terminal SH2 domain of p85α to activate PI3K, leading to enhanced AKT-dependent PFK2 activation, F-2,6-BP-production-dependent PFK1 activation, and GLUT1 expression. Non-metabolic function of PFKP promotes the Warburg effect through PI3K/AKT-dependent positive-feedback regulation.",
keywords = "EGFR, PFKP, phosphorylation, PI3K, the Warburg effect",
author = "Lee, {Jong Ho} and Rui Liu and Jing Li and Yugang Wang and Lin Tan and Li, {Xin Jian} and Xu Qian and Chuanbao Zhang and Yan Xia and Daqian Xu and Wei Guo and Zhiyong Ding and Linyong Du and Yanhua Zheng and Qianming Chen and Lorenzi, {Philip L.} and Gordon Mills and Tao Jiang and Zhimin Lu",
year = "2018",
month = "4",
day = "19",
doi = "10.1016/j.molcel.2018.03.018",
language = "English (US)",
volume = "70",
pages = "197--210.e7",
journal = "Molecular Cell",
issn = "1097-2765",
publisher = "Cell Press",
number = "2",

}

TY - JOUR

T1 - EGFR-Phosphorylated Platelet Isoform of Phosphofructokinase 1 Promotes PI3K Activation

AU - Lee, Jong Ho

AU - Liu, Rui

AU - Li, Jing

AU - Wang, Yugang

AU - Tan, Lin

AU - Li, Xin Jian

AU - Qian, Xu

AU - Zhang, Chuanbao

AU - Xia, Yan

AU - Xu, Daqian

AU - Guo, Wei

AU - Ding, Zhiyong

AU - Du, Linyong

AU - Zheng, Yanhua

AU - Chen, Qianming

AU - Lorenzi, Philip L.

AU - Mills, Gordon

AU - Jiang, Tao

AU - Lu, Zhimin

PY - 2018/4/19

Y1 - 2018/4/19

N2 - EGFR activates phosphatidylinositide 3-kinase (PI3K), but the mechanism underlying this activation is not completely understood. We demonstrated here that EGFR activation resulted in lysine acetyltransferase 5 (KAT5)-mediated K395 acetylation of the platelet isoform of phosphofructokinase 1 (PFKP) and subsequent translocation of PFKP to the plasma membrane, where the PFKP was phosphorylated at Y64 by EGFR. Phosphorylated PFKP binds to the N-terminal SH2 domain of p85α, which is distinct from binding of Gab1 to the C-terminal SH2 domain of p85α, and recruited p85α to the plasma membrane resulting in PI3K activation. PI3K-dependent AKT activation results in enhanced phosphofructokinase 2 (PFK2) phosphorylation and production of fructose-2,6-bisphosphate, which in turn promotes PFK1 activation. PFKP Y64 phosphorylation–enhanced PI3K/AKT-dependent PFK1 activation and GLUT1 expression promoted the Warburg effect, tumor cell proliferation, and brain tumorigenesis. These findings underscore the instrumental role of PFKP in PI3K activation and enhanced glycolysis through PI3K/AKT-dependent positive-feedback regulation. Lee et al. demonstrate that KAT5-mediated PFKP acetylation and subsequent EGFR-phosphorylated PFKP bind to the N-terminal SH2 domain of p85α to activate PI3K, leading to enhanced AKT-dependent PFK2 activation, F-2,6-BP-production-dependent PFK1 activation, and GLUT1 expression. Non-metabolic function of PFKP promotes the Warburg effect through PI3K/AKT-dependent positive-feedback regulation.

AB - EGFR activates phosphatidylinositide 3-kinase (PI3K), but the mechanism underlying this activation is not completely understood. We demonstrated here that EGFR activation resulted in lysine acetyltransferase 5 (KAT5)-mediated K395 acetylation of the platelet isoform of phosphofructokinase 1 (PFKP) and subsequent translocation of PFKP to the plasma membrane, where the PFKP was phosphorylated at Y64 by EGFR. Phosphorylated PFKP binds to the N-terminal SH2 domain of p85α, which is distinct from binding of Gab1 to the C-terminal SH2 domain of p85α, and recruited p85α to the plasma membrane resulting in PI3K activation. PI3K-dependent AKT activation results in enhanced phosphofructokinase 2 (PFK2) phosphorylation and production of fructose-2,6-bisphosphate, which in turn promotes PFK1 activation. PFKP Y64 phosphorylation–enhanced PI3K/AKT-dependent PFK1 activation and GLUT1 expression promoted the Warburg effect, tumor cell proliferation, and brain tumorigenesis. These findings underscore the instrumental role of PFKP in PI3K activation and enhanced glycolysis through PI3K/AKT-dependent positive-feedback regulation. Lee et al. demonstrate that KAT5-mediated PFKP acetylation and subsequent EGFR-phosphorylated PFKP bind to the N-terminal SH2 domain of p85α to activate PI3K, leading to enhanced AKT-dependent PFK2 activation, F-2,6-BP-production-dependent PFK1 activation, and GLUT1 expression. Non-metabolic function of PFKP promotes the Warburg effect through PI3K/AKT-dependent positive-feedback regulation.

KW - EGFR

KW - PFKP

KW - phosphorylation

KW - PI3K

KW - the Warburg effect

UR - http://www.scopus.com/inward/record.url?scp=85045312199&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045312199&partnerID=8YFLogxK

U2 - 10.1016/j.molcel.2018.03.018

DO - 10.1016/j.molcel.2018.03.018

M3 - Article

C2 - 29677490

AN - SCOPUS:85045312199

VL - 70

SP - 197-210.e7

JO - Molecular Cell

JF - Molecular Cell

SN - 1097-2765

IS - 2

ER -